AzTrials
AzTrials

Chronic Low Back PainPhase 1/2NCT00885001

The Effects of Short Arc Banding

A Phase 1/2 study testing Short Arc Banding in people with Chronic Low Back Pain, run by Logan College of Chiropractic at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The general purpose of this pilot study is to determine the effects of a novel exercise intervention (short arc banding (SAB)) on the cross sectional area of lumbar multifidus well as functional outcomes assessments in patients with chronic low back pain. Read more about this study

Who is it for?
Ages 18 to 55 years
Conditions the study is for
Chronic Low Back Pain
What is being tested?
Short Arc Banding
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited States
Study dates
Apr 2009to May 2009
Phase
Phase 1/2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Chronic mechanical low back pain (LBP) with a duration of greater than six weeks, severity and location remaining the same
  • No current radicular symptoms extending below the knee
  • Logan College Faculty, staff, as well as patients from any of Logan Health Center's allied clinics

Who cannot join

  • Current radicular symptoms extending below the knee
  • A history of neurological disease,
  • History of severe lumbar trauma or surgery
  • Contraindications to lumbar manipulation
  • Current use of muscle relaxants or analgesics
  • Degenerative joint disease (DJD)
Show all 11Show fewer
  • Recent spinal manipulative therapy (within 2 weeks of start of trial)
  • Current use of modalities (e-stim, vibration, etc) and other exercise
  • Diabetes
  • Heart, kidney thyroid disorders and chronic disease
  • Female subjects who are pregnant or breast feeding

Trial locations and contacts

1 site in 1 country.

United States1 site, 1 recruiting
  • Logan College of Chiropractic

    Chesterfield, Missouri, 63017

    Recruiting

Other trials in United States

About this study

Official title: The Effects of Short Arc Banding: A Novel Exercise Intervention in Patients With Chronic Low Back Pain

The general purpose of this pilot study is to determine the effects of a novel exercise intervention (short arc banding (SAB)) on the cross sectional area of lumbar multifidus well as functional outcomes assessments in patients with chronic low back pain.

Read the detailed description

Multifidus muscle is well known and documented to be a segmental spinal stabilizer and postural muscle. (Bajek, Bogduk) Previous studies have shown evidence that patients with low back pain (LBP) present with multifidus muscle atrophy. It has been documented that patients presenting with unilateral back pain demonstrate an ipsilateral state of reduced cross sectional area of lumbar multifidus (LM) at the segmental level of injury or pain.(Barker, Hides) Chronic LBP sufferers demonstrate a localized and segmentally specific decrease in cross sectional area of multifidus.(Hides) It has been theorized that multifidus muscle surrounding a chronically painful or degenerative segment is less able to stabilize the spine at that segment, predisposing chronic LBP patients to exacerbation due to the inability to cope with demands of day to day life. (Bajek)

Rehabilitative Ultrasound Imaging (RUSI) has been verified as accurate and reliable in determining cross sectional area of lumbar multifidus (Hides). The interrater and intrarater reliability of RUSI has been shown high utilizing a standardized protocol. (Hides) Measurement of LM contraction using RUSI has been shown a valid and useful measure to determine activation of LM as correlated with EMG. (Kiesel) RUSI has been correlated with MRI which is the gold standard for measuring CSA of LM. (Hides)

Type I muscle fibers are the predominant muscle fiber type in lumbar multifidus which has led researchers to pursue spinal stabilization exercises which focus on isometric contractions. These interventions stimulate mainly Type I muscle fibers because they do not use speed or loading parameters theorized necessary to stimulate Type II fibers. (Rissanen, Ng) Previous studies by Rantanen examined LM fiber type in post surgery low backs. Patients with good recovery (minimal to no symptoms 5 years after surgery) showed increased Type II muscle fiber type in relation to those with a poor recovery and Type I fibers increased. (Rantanen) Limited mobility might account for decrease in diameter in Type II fibers in patients undergoing lumbar surgeries.

Notably, Type I muscle fibers appear to increase in size in the presence of chronic LBP. This is probably due to chronic pain induced low tension muscle spasm. (Mattila, Rantanen) Stokes suggested that LM takes on an increasing role in spinal stability due to atrophy of other muscles, thus the increase in size of Type I fibers versus Type II.

To date, the effects of a short arc fast tapping exercise with band resistance or short arc banding (SAB) on the cross sectional area of multifidus has not been documented in the literature. Short arc banding is a novel exercise treatment and to our knowledge is the first study of this mode of exercise. Using a fast motion against band resistance we hope to reach threshold necessary to stimulate not only type I muscle fibers which predominate the LM, but also type II muscle fibers. From the literature, type II muscle fibers decrease in cross sectional area in the presence of a segmental spinal lesion such as lumbar disc herniation. Type II muscle fibers of multifidus aid the spine to respond to and stabilize a ballistic load. Since modern man is much more sedentary, lumbar spines are not loaded adequately to produce stimulation and maintain size of Type II muscle fibers

Being tested
Short Arc Banding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Short Arc BandingProcedure or surgery

    Lumbar extension on the ATM II from back project. Rehabilitation exercise intervention.

Study groups in NCT00885001
Study groupRoleWhat they receive
Short Arc Banding GroupExperimentalLumbar extension on the ATM II from back project. Rehabilitation exercise intervention.
Receives: Procedure: Short Arc Banding

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diagnostic ultrasound

    Measured: beginning of the trial, at the two week mark and the end of the trial

Secondary outcomes (2)
  1. Revised Oswestery Low Back Disability Questionnaire

    Measured: at the beginning and end of the trail

  2. Quadruple Visual Analogue Scale

    Measured: Beginning and end of the trial

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Apr 2009 (estimated)
  2. Study startApr 2009
  3. Primary completionMay 2009 (estimated)
  4. Study completionMay 2009 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00885001
Sponsor's protocol ID
RD0311090179
Other IDs
403
Status last verified
Apr 2009
First submitted
17 Apr 2009
Last updated
21 Apr 2009
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing Short Arc Banding in people with Chronic Low Back Pain, run by Logan College of Chiropractic at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Apr 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Adam Morrell, DC ((636) 227-2100 ext. 1812, Adam.Morrell@logan.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diagnostic ultrasound (time frame: beginning of the trial, at the two week mark and the end of the trial). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Apr 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in